Cargando…

Sex-dependent treatment of chronic EAE with partial MHC class II constructs

BACKGROUND: One of the main challenges in treating multiple sclerosis (MS) is reversing the effects of accumulated damage in the central nervous system (CNS) of progressive MS subjects. While most of the available drugs for MS subjects are anti-inflammatory and thus are limited to relapsing-remittin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benedek, Gil, Chaudhary, Priya, Meza-Romero, Roberto, Calkins, Evan, Kent, Gail, Offner, Halina, Bourdette, Dennis, Vandenbark, Arthur A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420407/ https://www.ncbi.nlm.nih.gov/pubmed/28477623 http://dx.doi.org/10.1186/s12974-017-0873-y

Ejemplares similares

Spleen participation in partial MHC class II construct neuroprotection in stroke
por: Brown, John, et al.
Publicado: (2020)

Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
por: Seifert, Hilary A., et al.
Publicado: (2019)

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
por: Vandenbark, Arthur A., et al.
Publicado: (2019)

Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model
por: Zerimech, Sarah, et al.
Publicado: (2023)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction
por: Loftis, Jennifer M., et al.
Publicado: (2013)

RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
por: Sinha, Sushmita, et al.
Publicado: (2011)

Major histocompatibility complex Class II-based therapy for stroke
por: Gonzales-Portillo, Bella M., et al.
Publicado: (2021)

Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
por: Matejuk, Agata, et al.
Publicado: (2021)

Microglia and astrocyte involvement in neurodegeneration and brain cancer
por: Vandenbark, Arthur A., et al.
Publicado: (2021)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
por: Marín, Nieves, et al.
Publicado: (2014)

PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
por: Bodhankar, Sheetal, et al.
Publicado: (2013)

Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
por: Bodhankar, Sheetal, et al.
Publicado: (2014)

Single Chain Recombinant HLA-DQ2.5/peptide Molecules Block α2-gliadin-Specific Pathogenic CD4(+) T Cell Proliferation and Attenuate Production of Inflammatory Cytokines: A Potential Therapy for Celiac Disease
por: Huan, J, et al.
Publicado: (2010)

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study
por: Yadav, Vijayshree, et al.
Publicado: (2012)

Characterization of human platelet binding of recombinant T cell receptor ligand
por: Itakura, Asako, et al.
Publicado: (2010)

The partial dissociation of MHC class I–bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1
por: Papakyriakou, Athanasios, et al.
Publicado: (2018)

A microwave method for plastic embedding of nervous tissue for light and electron microscopy
por: Calkins, Evan, et al.
Publicado: (2019)

Novel Humanized Recombinant T Cell Receptor Ligands Protect the Female Brain After Experimental Stroke
por: Pan, Jie, et al.
Publicado: (2014)

Glatiramer Acetate Treatment Increases Stability of Spinal Synapses and Down Regulates MHC I during the Course of EAE
por: Scorisa, Juliana M., et al.
Publicado: (2011)

MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Rethinking EAE pathogenesis
por: Van Epps, Heather L.
Publicado: (2005)

PARing down EAE
por: Van Epps, Heather L.
Publicado: (2006)

Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II
por: Masaki, Kento, et al.
Publicado: (2020)

Structures of peptide-free and partially loaded MHC class I molecules reveal mechanisms of peptide selection
por: Anjanappa, Raghavendra, et al.
Publicado: (2020)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Thomas Rivers and the EAE model
por: Van Epps, Heather L.
Publicado: (2005)

Role of Microglia and Macrophages in Eae
por: Raivich, Gennadij, et al.
Publicado: (2005)

Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta
Publicado: (1990)

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells
Publicado: (1984)

MHC class I diversity in chimpanzees and bonobos
por: Maibach, Vincent, et al.
Publicado: (2017)

MHC Class I Regulation: The Origin Perspective
por: Sznarkowska, Alicja, et al.
Publicado: (2020)

MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis
por: Harrington, Em P, et al.
Publicado: (2023)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

The EAES intellectual property awareness survey
por: Nakajima, Kiyokazu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3qd5gsjja0gl6jlq5bcnunlhh7